Section Arrow
Quote
TAK.NYSE
- Takeda Pharmaceutical Company Limited
Quotes are at least 15-min delayed:2025/02/23 10:28 EST
Last
 14.06
+0.2 (+1.44%)
Day High 
14.1 
Prev. Close
13.86 
1-M High
13.97 
Volume 
1.47M 
Bid
13.75
Ask
14.25
Day Low
13.93 
Open
13.93 
1-M Low
12.8 
Market Cap 
43.94B 
Currency USD 
P/E 31.99 
%Yield 4.4 
10-SMA 13.59 
20-SMA 13.45 
50-SMA 13.31 
52-W High 15.08 
52-W Low 12.575 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
64.84/58.59
Enterprise Value
4,520.44B
Balance Sheet
Book Value Per Share
15.45
Cash Flow
Cash Flow Yield
0.17
Income Statement
Total Revenue
4,263.76B
Operating Revenue Per Share
8.77
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 10:28 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.